Shi-yuan Cheng
North Western University
H-index: 59
Asia-Bangladesh
Top articles of Shi-yuan Cheng
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma
ACS Medicinal Chemistry Letters
2024/1/16
Shi-Yuan Cheng
H-Index: 36
CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity
Neuro-oncology
2024/1/1
Shi-Yuan Cheng
H-Index: 36
Repurposing clemastine to target glioblastoma cell stemness
Cancers
2023/9/18
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis
Neuro-oncology
2023/9/1
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis
Acta Neuropathologica Communications
2023/8/14
The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy
2023/4/22
PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines
Database
2023/1/1
Current Research in Chemical Biology
2023
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
Current research in chemical biology
2023/1/1
Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B
2023/10/24
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas
Science Advances
2022/6/22
Unconventional protein secretion in brain tumors biology: Enlightening the mechanisms for tumor survival and progression
2022/6/15
New life for an old therapy: ELTD1 as a downstream target of angiogenesis
2022/3/1
Shi-Yuan Cheng
H-Index: 36
DNA damage and metabolic mechanisms of cancer drug resistance
2022
Shi-Yuan Cheng
H-Index: 36
SGC-CLK-1 (CAF-170) a chemical probe for the Cdc2-Like kinases CLK1, CLK2, and CLK4
bioRxiv
2022/12/18
Modeling therapy-driven evolution of glioblastoma with patient-derived xenografts
Cancers
2022/11/9
CNSC-06. TEMOZOLOMIDE-INDUCED GUANINE MUTATIONS CREATE EXPLOITABLE VULNERABILITIES OF GUANINE-RICH DNA AND RNA REGIONS IN DRUG-RESISTANT GLIOMAS
Neuro-Oncology
2022/11
STEM-21. REPURPOSING CLEMASTINE TO SUPPRESS GLIOBLASTOMA STEM CELLS
Neuro-Oncology
2022/11
CSIG-14. THE PDGFRA-REGULATING LNCRNA LINC02283 IS AMPLIFIED IN HIGH-GRADE GLIOMA AND FACILITATES GLIOMAGENESIS
Neuro-Oncology
2022/11
Retracted: Targeting neddylation in cancer
2022/11/1
Anshika Goenka
H-Index: 3
Shi-Yuan Cheng
H-Index: 36
Co-Authors
